in3

in3

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2017 - 31 Dec 2021
Client: 
Marie Skłodowska-Curie Action - Innovative Training Network (H2020)

ABOUT THIS PROJECT

The Marie Skłodowska-Curie Innovative Training Network in3 aims to drive the synergistic development and utilisation of in vitro and in silico tools for human chemical and nanomaterial safety assessment. State-of-the-art human induced pluripotent stem cells research, cheminformatics, mechanistic toxicology and biokinetics are integrated safety assessment approaches. DC is hosting one of the 15 PhD students working on data management and integration, harmonization of analysis workflows and biomarker identification for key events of adverse outcome pathways. Recruitment for this and other positions in the network is still ongoing.

Latest Tweets

Edelweiss Connect (5 weeks ago)
Save the date! June 29 at 16 CEST #SaferWorldbyDesign webinar with @MultiCASEInc Title: Use of in silico methods… https://t.co/lr1AsHxSHs
Edelweiss Connect (5 weeks ago)
The first of these new additions is the HepaRG™ Gene Expression Tool which supports users querying gene expression… https://t.co/ydsXlaV6JD
Edelweiss Connect (5 weeks ago)
Provision of HepaRG™ on SaferWorldbyDesign @wepredic/@Biopredic_Intl adding #hepaRG to the #SaferWorldbyDesign pl… https://t.co/ftFGWQ697r
Edelweiss Connect (5 weeks ago)
Join us and #SaferWorldbyDesign partner @Biobide_ for a webinar and discussion Tuesday, June 22 at 16 CEST Teratog… https://t.co/YF8BUygT2E
Edelweiss Connect (5 weeks ago)
RT @Biobide_: Today is the #InternationalALS/MNDAllianceDay! A day of world recognition of ALS/MND, a disease that affects people in every…

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA